Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
A | 0.840 | GeneticVariation | GWASDB | Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. | 22693455 | 2012 |
|||
|
A | 0.840 | GeneticVariation | GWASCAT | Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. | 22693455 | 2012 |
|||
|
A | 0.840 | GeneticVariation | GWASCAT | Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. | 22885922 | 2012 |
|||
|
0.840 | GeneticVariation | GWASDB | Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. | 22885922 | 2012 |
||||
|
0.800 | GeneticVariation | GWASDB | Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. | 22885922 | 2012 |
||||
|
T | 0.800 | GeneticVariation | GWASCAT | Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. | 22885922 | 2012 |
|||
|
T | 0.800 | GeneticVariation | GWASCAT | Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. | 24509480 | 2014 |
|||
|
T | 0.800 | GeneticVariation | GWASDB | Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. | 24509480 | 2014 |
|||
|
G | 0.840 | GeneticVariation | GWASCAT | Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. | 28869590 | 2017 |
|||
|
G | 0.840 | GeneticVariation | GWASCAT | Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. | 30054458 | 2018 |
|||
|
0.700 | GeneticVariation | GWASCAT | Leveraging Polygenic Functional Enrichment to Improve GWAS Power. | 30595370 | 2019 |